Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
119,820
+8,762
+8% +$1.06M 0.03% 411
2026
Q1
$18.2M Buy
111,058
+800
+0.7% +$123K 0.04% 309
2025
Q4
$19.2M Buy
110,258
+107,858
+4,494% +$19.7M 0.04% 310
2025
Q3
$346K Hold
2,400
﹤0.01% 790
2025
Q2
$242K Buy
2,400
+2,100
+700% +$161K ﹤0.01% 785
2025
Q1
$22.9K Hold
300
﹤0.01% 988
2024
Q4
$20.7K Sell
300
-1,600
-84% -$115K ﹤0.01% 1002
2024
Q3
$139K Buy
+1,900
New +$140K ﹤0.01% 972
2024
Q2
Sell
-86,100
Closed -$2.34M 1203
2024
Q1
$2.34M Buy
+86,100
New +$2.41M 0.01% 663

Other funds holding INSM

Danske Bank's INSM Position: Q2 2026 in Review

Danske Bank increased its Insmed (INSM) stake by 7.9% in Q2 2026, buying an estimated $1.06M and bringing the position to 119,820 shares worth $12.8M. The position accounts for 0.03% of the portfolio, ranked #411.

Danske Bank first reported a position in INSM in Q1 2024 and has held it in 9 quarters since. The position peaked at $19.2M in Q4 2025. 456 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Danske Bank held 119,820 shares of Insmed worth $12.8M as of Q2 2026.
  • Danske Bank bought 8,762 Insmed shares in Q2 2026, an estimated $1.06M.
  • Insmed made up 0.03% of Danske Bank's portfolio in Q2 2026, its #411 holding.
  • Danske Bank first reported a position in Insmed in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's Insmed position peaked at $19.2M in Q4 2025.
  • 456 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.